» Articles » PMID: 9016279

Major Depression Following Smoking Cessation

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 1997 Feb 1
PMID 9016279
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The authors examined the incidence and predictors of major depression following successful smoking cessation treatment, with special attention to the influence of past major depression.

Method: Three-month follow-up data were obtained from 126 subjects who successfully completed a 10-week smoking cessation program.

Results: The 3-month incidence of new major depression following treatment for nicotine dependence was 2%, 17%, and 30% among subjects with histories of no major depression, single major depression, and recurrent major depression, respectively. A history of major depression and persistent withdrawal symptoms independently predicted posttreatment major depression.

Conclusions: Continued patient care beyond the 2-4-week period associated with the nicotine withdrawal syndrome is indicated when abstinence is attempted by smokers with prior major depression.

Citing Articles

The Role of Mindful Attention in Regard to the Relation Between Negative Affect Reduction Outcome Expectancies and Emotional Vulnerability Among Adult Cigarette Smokers.

Gonzalez A, Vujanovic A, Johnson K, Leyro T, Zvolensky M Cognit Ther Res. 2020; 33(6):645-656.

PMID: 32773908 PMC: 7410363. DOI: 10.1007/s10608-009-9246-x.


Longitudinal Association Between Smoking Abstinence and Depression Severity in Those With Baseline Current, Past, and No History of Major Depressive Episode in an International Online Tobacco Cessation Study.

Liu N, Wu C, Perez-Stable E, Munoz R Nicotine Tob Res. 2020; 23(2):267-275.

PMID: 32149344 PMC: 7822114. DOI: 10.1093/ntr/ntaa036.


Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression.

Zhou H, Cheng Z, Bass N, Krystal J, Farrer L, Kranzler H Transl Psychiatry. 2018; 8(1):208.

PMID: 30287806 PMC: 6172277. DOI: 10.1038/s41398-018-0258-8.


Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.

Dulawa S, Janowsky D Mol Psychiatry. 2018; 24(5):694-709.

PMID: 30120418 PMC: 7192315. DOI: 10.1038/s41380-018-0219-x.


Lifetime Depression, Other Mental Illness, and Smoking Cessation.

Huffman A, Bromberg J, Augustson E Am J Health Behav. 2018; 42(4):90-101.

PMID: 29973314 PMC: 6050019. DOI: 10.5993/AJHB.42.4.9.